Ceramides Mixture 神经酰胺混合物,98.33%
产品编号:Bellancom-113679| CAS NO:100403-19-8| 分子式:C24H47NO3| 分子量:397.63488
Ceramides Mixture 是一种内源性神经酰胺,由含羟基和非羟基脂肪酸的神经酰胺组成。Ceramides Mixture 是表皮渗透屏障的主要脂质成分。Ceramides Mixture 参与生长抑制,细胞周期停滞和端粒酶 (telomerase) 活性的调节。
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Ceramides Mixture 神经酰胺混合物
产品介绍 | Ceramides Mixture 是一种内源性神经酰胺,由含羟基和非羟基脂肪酸的神经酰胺组成。Ceramides Mixture 是表皮渗透屏障的主要脂质成分。Ceramides Mixture 参与生长抑制,细胞周期停滞和端粒酶 (telomerase) 活性的调节。 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | Ceramides Mixture is an endogenous ceramide and consists of hydroxy and non-hydroxy fatty acid-containing ceramides. Ceramides Mixture is a main lipid component of the permeability barrier in epidermis. Ceramides Mixture is involved in the regulation of growth inhibition, cell cycle arrest, and modulation of telomerase activity. | ||||||||||||
体外研究 |
Endogenous Ceramides (generated in response to bacterial sphingomyelinase overexpression or daunorubicin treatment) inhibits mRNA synthesis of telomerase reverse transcriptase and telomerase activity via inactivation of c-Myc transcription factor in the A549 human lung adenocarcinoma cell line. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||
体内研究 | |||||||||||||
体内研究 | |||||||||||||
性状 | Solid | ||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (Need ultrasonic) H2O : 33.33 mg/mL (Need ultrasonic) Methanol : 25 mg/mL (Need ultrasonic) In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
| ||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||
储存方式 |
| ||||||||||||
参考文献 |
|

匹配竞争对手的价格

效率为先

专业经验 贴心服务

50000+库存